Acetabular Reconstructions in Patients with Severe Defects: Literature Review and Clinical Outcomes
By Kim Pauwels, Market Access Manager, Materialise
Three out of 25 patients who need an acetabular reconstruction have a severe defect classified as Paprosky type III or AAOS type III-IV. In these cases, ensuring a sustainable solution for the patient becomes particularly challenging.
Many studies have explored the clinical outcomes of standard versus personalized implants for acetabular reconstructions. However, specific outcomes for patients with severe acetabular defects have received little focus.
This webinar explores the results of a literature search aimed to evaluate clinical outcomes for patients with severe acetabular defects. It looks at differences between using modular systems with standard components and personalized solutions, like CTAC and Materialise aMace.
In this recording, you will learn:
That studies on standard implants report higher implant failure rates than personalized solutions when focusing on patients with severe defects.
Patients with even the most severe defects and low pre-operative Harris Hip Scores can achieve good clinical outcomes with personalized solutions.
Adverse events such as infection are limited with personalized solutions.
THIS INFORMATION IS INTENDED FOR HEALTHCARE PROFESSIONALS ONLY